RS20060086A - Antagonistic analogs of gh-rh(2003) - Google Patents
Antagonistic analogs of gh-rh(2003)Info
- Publication number
- RS20060086A RS20060086A YUP-2006/0086A YUP20060086A RS20060086A RS 20060086 A RS20060086 A RS 20060086A YU P20060086 A YUP20060086 A YU P20060086A RS 20060086 A RS20060086 A RS 20060086A
- Authority
- RS
- Serbia
- Prior art keywords
- analogs
- inhibit
- hgh
- antagonistic analogs
- antagonistic
- Prior art date
Links
- 230000003042 antagnostic effect Effects 0.000 title abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 2
- 102000018997 Growth Hormone Human genes 0.000 abstract 1
- 108010051696 Growth Hormone Proteins 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 239000000122 growth hormone Substances 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000001817 pituitary effect Effects 0.000 abstract 1
- 230000036515 potency Effects 0.000 abstract 1
- 230000035755 proliferation Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/60—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Endocrinology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Genetics & Genomics (AREA)
- Animal Behavior & Ethology (AREA)
- Biochemistry (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
Obezbeđene su nove serije sintetskih analoga antagonista hGH-RH(1-29)NH2• Ovi analozi inhibiraju aktivnost endogenog hGH-RH na receptore za GH-RH hipofize i time sprečavaju oslobađanje hormona rasta. Analozi, takođe, inhibiraju proliferaciju humanih kancera preko direktnog dejstva na kancerske ćelije. Veće inhibitorne mogućnosti novih analoga u poređenju sa prethodno opisanim, dobijene su zamenom raznih aminokiselina.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US49270603P | 2003-08-05 | 2003-08-05 | |
PCT/US2004/024183 WO2005016953A2 (en) | 2003-08-05 | 2004-07-26 | Antagonistic analogs of gh-rh (2003) |
Publications (1)
Publication Number | Publication Date |
---|---|
RS20060086A true RS20060086A (en) | 2008-08-07 |
Family
ID=34193144
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YUP-2006/0086A RS20060086A (en) | 2003-08-05 | 2004-07-26 | Antagonistic analogs of gh-rh(2003) |
Country Status (19)
Country | Link |
---|---|
US (1) | US7452865B2 (sr) |
EP (1) | EP1651662A4 (sr) |
JP (1) | JP2007526900A (sr) |
KR (1) | KR20060088875A (sr) |
CN (1) | CN1871020A (sr) |
AR (1) | AR049149A1 (sr) |
AU (1) | AU2004265280A1 (sr) |
BR (1) | BRPI0413257A (sr) |
CA (1) | CA2534436A1 (sr) |
IL (1) | IL173201A0 (sr) |
MX (1) | MXPA06001369A (sr) |
NO (1) | NO20061060L (sr) |
PL (1) | PL380437A1 (sr) |
RS (1) | RS20060086A (sr) |
RU (1) | RU2335506C2 (sr) |
SG (1) | SG136958A1 (sr) |
TW (1) | TW200517400A (sr) |
WO (1) | WO2005016953A2 (sr) |
ZA (1) | ZA200600966B (sr) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009108364A2 (en) * | 2008-02-27 | 2009-09-03 | Ipsen Pharma S.A.S. | Antagonistic analogues of ghrh |
US8691942B2 (en) | 2008-03-28 | 2014-04-08 | University Of Miami | N- and C- terminal substituted antagonistic analogs of GH-RH |
MX2010010642A (es) * | 2008-03-28 | 2011-03-29 | The Univ Of Miami | Nuevos analogos antagonistas, sustituidos, n- y c- terminales, de hormona liberadora de hormona de crecimiento (gh-rh). |
US20110171191A1 (en) * | 2008-06-12 | 2011-07-14 | Syntaxin Limited | Suppression of neuroendocrine diseases |
US10240138B2 (en) | 2008-06-12 | 2019-03-26 | Ipsen Bioinnovation Limited | Polypeptides that bind to and inhibit secretion from growth hormone secreting cells |
US8796216B2 (en) | 2008-06-12 | 2014-08-05 | Syntaxin Limited | Suppression of neuroendocrine diseases |
US8227421B2 (en) | 2009-09-17 | 2012-07-24 | University Of Miami | Fluorinated GHRH antagonists |
WO2011153491A2 (en) | 2010-06-03 | 2011-12-08 | University Of Miami | Agonists of growth hormone releasing hormone as effectors for survival and proliferation of pancreatic islets |
JP6113144B2 (ja) | 2011-04-21 | 2017-04-12 | セラテクノロジーズ・インコーポレーテッド | 成長ホルモン放出因子(grf)類似体およびその使用 |
US9079974B2 (en) | 2011-12-21 | 2015-07-14 | The University Of Miami | GH-RH analogs with potent agonistic effects |
US20150166617A1 (en) * | 2012-06-27 | 2015-06-18 | University Of Miami | Compositions and methods of treating alzheimer's disease |
WO2014100809A2 (en) | 2012-12-21 | 2014-06-26 | University Of Miami | Ghrh agonists for the treatment of ischemic disorders |
EP2935317B1 (en) | 2012-12-21 | 2019-03-27 | University of Miami | Ghrh agonists for islet cell transplantation and function and the treatment of diabetes |
AU2020218272A1 (en) | 2019-02-08 | 2021-09-02 | United States Government As Represented By The Department Of Veterans Affairs | Growth hormone-releasing hormone antagonists and uses thereof |
CA3178840A1 (en) | 2020-04-27 | 2021-11-04 | The University Of Miami | Method of treating an inflammatory disorder |
CN114195881B (zh) * | 2021-12-16 | 2022-09-16 | 浙江湃肽生物股份有限公司 | 一种制备醋酸舍莫瑞林的方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5942489A (en) * | 1996-05-03 | 1999-08-24 | The Administrators Of The Tulane Educational Fund | HGH-RH(1-29)NH2 analogues having antagonistic activity |
US6057422A (en) * | 1998-11-25 | 2000-05-02 | The Administrators Of The Tulane Educational Fund | Antagonistic analogs of GH-RH inhibiting IGF-I and -II |
-
2004
- 2004-07-23 TW TW093121985A patent/TW200517400A/zh unknown
- 2004-07-26 RS YUP-2006/0086A patent/RS20060086A/sr unknown
- 2004-07-26 EP EP04757325A patent/EP1651662A4/en not_active Withdrawn
- 2004-07-26 RU RU2006106701/04A patent/RU2335506C2/ru not_active IP Right Cessation
- 2004-07-26 JP JP2006522602A patent/JP2007526900A/ja active Pending
- 2004-07-26 MX MXPA06001369A patent/MXPA06001369A/es unknown
- 2004-07-26 CN CNA2004800222868A patent/CN1871020A/zh active Pending
- 2004-07-26 PL PL380437A patent/PL380437A1/pl unknown
- 2004-07-26 WO PCT/US2004/024183 patent/WO2005016953A2/en active Application Filing
- 2004-07-26 US US10/566,776 patent/US7452865B2/en not_active Expired - Fee Related
- 2004-07-26 KR KR1020067002465A patent/KR20060088875A/ko active IP Right Grant
- 2004-07-26 BR BRPI0413257-2A patent/BRPI0413257A/pt not_active IP Right Cessation
- 2004-07-26 SG SG200716961-8A patent/SG136958A1/en unknown
- 2004-07-26 CA CA002534436A patent/CA2534436A1/en not_active Abandoned
- 2004-07-26 AU AU2004265280A patent/AU2004265280A1/en not_active Abandoned
- 2004-08-03 AR ARP040102755A patent/AR049149A1/es unknown
-
2006
- 2006-01-17 IL IL173201A patent/IL173201A0/en unknown
- 2006-02-02 ZA ZA200600966A patent/ZA200600966B/en unknown
- 2006-03-03 NO NO20061060A patent/NO20061060L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JP2007526900A (ja) | 2007-09-20 |
PL380437A1 (pl) | 2007-01-22 |
US20070042950A1 (en) | 2007-02-22 |
WO2005016953A2 (en) | 2005-02-24 |
CA2534436A1 (en) | 2005-02-24 |
TW200517400A (en) | 2005-06-01 |
US7452865B2 (en) | 2008-11-18 |
KR20060088875A (ko) | 2006-08-07 |
SG136958A1 (en) | 2007-11-29 |
WO2005016953A3 (en) | 2006-02-09 |
RU2006106701A (ru) | 2007-09-20 |
AR049149A1 (es) | 2006-07-05 |
NO20061060L (no) | 2006-05-03 |
CN1871020A (zh) | 2006-11-29 |
EP1651662A2 (en) | 2006-05-03 |
AU2004265280A1 (en) | 2005-02-24 |
ZA200600966B (en) | 2007-05-30 |
EP1651662A4 (en) | 2009-07-01 |
RU2335506C2 (ru) | 2008-10-10 |
BRPI0413257A (pt) | 2006-10-03 |
IL173201A0 (en) | 2006-06-11 |
MXPA06001369A (es) | 2007-02-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW200517400A (en) | Antagonistic analogs of GH-RH (2003) | |
TR199701356A2 (xx) | L�kozit adhasyonu inhibit�rleri ve VLA-4-antagonistleri olarak heterosiklenler. | |
MY138258A (en) | Growth hormone secretagogues | |
MX9500072A (es) | Compuestos con propiedades de liberacion de la hormona del crecimiento. | |
UA66825C2 (uk) | Азаполіциклічні сполуки, конденсовані з арилом, фармацевтична композиція, спосіб лікування та спосіб зниження нікотинової залежності | |
DE60045524D1 (de) | Ein Huhn GnRH-II Analog zur Verwendung in der Reduktion des Tumorzellwachstums | |
CO5280048A1 (es) | Agonistas del receptor 3 (r3) del peptido activador de la adenilato ciclasa de la pituitaria | |
ATE78831T1 (de) | Biologisch wirksame lysin enthaltende octapeptide. | |
GEP20084487B (en) | Polymer conjugates of cytokines, chemokines, growth factors, polypeptide hormones and antagonists thereof | |
MX9705710A (es) | Compuestos con propiedades de liberacion de la hormona del crecimiento. | |
BG105638A (en) | Antagonist analogs of gh-rh inhibiting igf-i and -ii | |
WO2009120831A3 (en) | Novel n-and c-terminal substituted -antagonistic analogs of human gh-rh | |
YU70199A (sh) | Primena stimulatora lučenja hormona rasta za izradu farmaceutskih preparata za lečenje otpornosti na insulin | |
DE69723728D1 (de) | Totalsynthese des amino hip analogen von didemnin a | |
CO5140111A1 (es) | Tratamiento de tumores mediante la administracion de compuestos que induce la liberacion de la hormona de crecimiento y sus antagonistas | |
BG106008A (en) | Novel lhrh antagonists with improved solubility characteristics | |
TW200501963A (en) | Pharmaceutical compositions comprising epinastine for the treatment of skin diseases | |
EP0973518A4 (en) | SEMI-SYNTHETIC PROCESSES FOR THE PREPARATION OF DIDEMNINE ANALOGS | |
ATE316078T1 (de) | 1,3,5-triazine-2,4,6-trione, herstellung und anwendungen als antagonisten der gonadotropin- freisetzenden hormonrezeptoren | |
UA66817C2 (uk) | Збиральна машина | |
WO2009108364A3 (en) | Antagonistic analogues of ghrh | |
SG146692A1 (en) | Melanin concentrating hormone antagonists | |
AU2003220441A8 (en) | Dipeptidic growth hormone secretagogues | |
NZ512664A (en) | Use of growth hormone secretagogues for stimulating or increasing appetite | |
AR044852A1 (es) | Una composicion farmaceutica para la administracion parenteral que comprende un analogo de somatostatina |